News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Jeffrey Peppercorn is JCO Oncology Practice’s 2023 Impact Factor of 4.7!
Photo of Jeffrey Peppercorn from researchers.mgh.harvard.edu
Jul 2, 2024, 14:01

Jeffrey Peppercorn is JCO Oncology Practice’s 2023 Impact Factor of 4.7!

Jeffrey Peppercorn,  Editor-in-Chief JCO Oncology Practice, shared on X:

“JCO Oncology Practice is proud to announce our 2023 Impact Factor of 4.7!

Thank you to our dedicated authors, reviewers, and readers!

Submit your impactful research and commentary on cancer care delivery and policy today!”

Source: Jeffrey Peppercorn/X

.

cancer cancer care Cancer research Impact Factor impactful researc JCO Oncology Practice Jeffrey Peppercorn OncoDaily Oncology
Special Coverage
Voices
Aug 25, 2025, 20:13
Ahmed Warrad: A Transformative Journey in Pediatric Oncology at Burjeel Medical City
Voices
Aug 25, 2025, 19:54
Daniel Kelly Highlighted Peter Sasieni’s Take on HPV and Cancer Prevention
Voices
Aug 25, 2025, 19:00
Jarushka Naidoo: Irish Oncology in Full Force at the ESMO Academy 2025
Voices
Aug 25, 2025, 18:30
Shadha S. Al-Raisi: The Latest Cancer Incidence Report in Oman Has Been Released
Insight
Aug 25, 2025, 17:47
Alexey Kulikov: Key Findings from the Recent Meta-Analysis on Daily Steps and Health Outcomes
Voices
Aug 25, 2025, 17:36
Lauren Kriger Groner: Learning to Make White Ribbons from the Very Best
Science
Aug 25, 2025, 17:28
Galip Can Uyar: How GA-Guided Care Improves Coping in Older Adults with Metastatic Cancer
Science
Aug 25, 2025, 17:18
Giuseppe Banna: Deferred Nephrectomy after ICI in RCC May Enable Treatment De-Escalation
Science
Aug 25, 2025, 17:08
Moazzam Shahzad: Upfront Immunotherapy Approaches in the Management of Adults with ALL
Science
Aug 25, 2025, 17:00
Chris Poulios: Pathologist-Read vs AI-Driven Assessment of Tumor-Infiltrating Lymphocytes in Melanoma
Voices
Aug 25, 2025, 16:44
Martin Zapata Laguado: Honored to Speak on mRCC First-Line Therapy and dCN in the IO Era
Voices
Aug 25, 2025, 16:30
Sarcoma 101 at Fellowship Bootcamp with Steve Bialick - Miami Hematology Oncology Program Director